Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Update

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) saw a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 888,600 shares, a decline of 15.4% from the April 30th total of 1,050,000 shares. Based on an average trading volume of 209,500 shares, the days-to-cover ratio is currently 4.2 days. Approximately 2.6% of the company's shares are short sold.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Jones Financial Companies Lllp raised its position in Bioceres Crop Solutions by 3,535.8% during the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock worth $25,000 after purchasing an additional 5,339 shares during the last quarter. Bank of America Corp DE increased its stake in Bioceres Crop Solutions by 186.8% in the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after purchasing an additional 3,735 shares in the last quarter. Jump Financial LLC bought a new stake in Bioceres Crop Solutions in the 4th quarter valued at about $72,000. Avanza Fonder AB bought a new stake in shares of Bioceres Crop Solutions during the first quarter valued at approximately $72,000. Finally, PDT Partners LLC bought a new stake in shares of Bioceres Crop Solutions during the first quarter worth about $81,000. Institutional investors own 17.68% of the company's stock.

Analysts Set New Price Targets

BIOX has been the subject of a number of recent analyst reports. Canaccord Genuity Group dropped their price objective on Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating for the company in a report on Thursday, February 13th. Lake Street Capital lowered their price target on Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating for the company in a research note on Friday, February 7th. Finally, Oppenheimer lowered their target price on shares of Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating for the company in a research note on Tuesday, April 22nd. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $8.63.

Bioceres Crop Solutions Stock Performance

NASDAQ BIOX traded up $0.16 during trading on Friday, reaching $5.05. The company's stock had a trading volume of 83,904 shares, compared to its average volume of 174,537. The firm has a 50 day moving average price of $4.44 and a 200 day moving average price of $5.37. The firm has a market capitalization of $316.69 million, a price-to-earnings ratio of 252.63 and a beta of 0.44. The company has a current ratio of 1.33, a quick ratio of 0.96 and a debt-to-equity ratio of 0.43. Bioceres Crop Solutions has a 12 month low of $3.51 and a 12 month high of $11.78.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its earnings results on Wednesday, May 21st. The company reported ($0.02) earnings per share for the quarter, beating analysts' consensus estimates of ($0.10) by $0.08. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.58%. The firm had revenue of $59.60 million during the quarter, compared to the consensus estimate of $61.80 million. As a group, equities analysts anticipate that Bioceres Crop Solutions will post -0.05 EPS for the current fiscal year.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.